About Generica India
Generica India is a Consumer company based in Delhi (India). Markets and distributes healthcare products with a nationwide network in India. It operates on a B2B model in Consumer and Healthcare sectors. The company has 74 employees. Its Indian entity Generica India Limited reported revenue of ₹236 Cr. Generica India offers products and services including Morepen Alpha Products, Morepen Beta Products, Morepen Genesis Products, and DML Lifespring Products. Its focus areas include Consumer Goods, Health Supplements, Daily Essentials and Pharmaceuticals. Similar companies include Entero Healthcare, Keimed and Sandor Medicaids; 3 of its 3 listed similar companies have raised funding.
Company details
Generica India Limited operates as a leading healthcare marketing and distribution firm based in Delhi, India. It focuses on partnering with companies like Morepen Laboratories to supply pharmaceutical products across major therapeutic segments. The company emphasizes quality, innovation, and sustainable growth through an extensive distribution network. It serves as national marketing agents for various divisions, handling products from food supplements to sanitizers, and maintains compliance with government norms while prioritizing customer satisfaction and reliable services.
- Headquarters Delhi, India
- Employees 74
- SectorsConsumerHealthcare
- Email••••••••
- Phone•••• ••••
- Website genericaindia.com
- Legal Name Generica India Limited
- Date of Incorporation 19 May, 1999
- Jurisdiction New Delhi, Delhi, India
- Annual Revenue₹236 Cr
FY 2025 · +14% YoY
- Net Profit₹7.01 Cr
FY 2025 · 3% margin
- EBITDA₹9.87 Cr
FY 2025 · 4% margin
- Employee Count74
Associated legal entities of Generica India
Generica India operates through Generica India Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Generica India Limited CIN U52311DL1999PLC099819 | Active | 19 May 1999 | New Delhi, Delhi | ₹236 Cr | 74 | 4 | View details |
Products & Services of Generica India
Generica India offers a comprehensive portfolio of products and services, including Morepen Alpha Products, Morepen Beta Products, Morepen Genesis Products, and DML Lifespring Products.
Wide range of products covering major therapeutic segments
Specialized products with advanced packaging for niche markets
Comprehensive range for competitive market positioning
Variety from supplements to sanitizers and external applications
Board of directors of Generica India Limited (Generica India)
Generica India Limited is the primary company behind Generica India. The board of Generica India Limited currently have 4 directors; the longest-serving is Anil Mediratta, appointed in 1999. 5 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Anil Mediratta DIN 00106741 | Managing Director | 19 May 1999 | 27 yrs 5 mo | Generica India Limited |
| Amit Mediratta DIN 00287961 | Whole-time director | 01 Dec 2001 | 24 yrs 11 mo | Generica India Limited |
| Hemraj Thakur DIN 07543428 | Director | 20 Jun 2016 | 10 yrs 4 mo | Generica India Limited |
| Arun Khanna DIN 09398589 | Director | 17 Nov 2021 | 4 yrs 11 mo | Generica India Limited |
People of Generica India
1 people are tracked at Generica India (1 in leadership); the tracked headcount is 74.
| Name | Role | Group |
|---|---|---|
| Owner | Leadership |
Complete people profiles for Generica India
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Generica India
Figures of Generica India Limited, the primary company behind Generica India, for FY 2025. Revenue was ₹236 Cr (+14% year on year). Net profit was ₹7.01 Cr (3% margin). EBITDA was ₹9.87 Cr (4% margin). Revenue has grown at a compounded annual rate of +13% over three years and +9% over five years.
- ₹236 CrRevenue · FY 2025 · +14% YoY
- ₹7.01 CrNet profit · 3% margin
- ₹9.87 CrEBITDA · 4% margin
- ₹1.01 CrPaid-up capital
- 74Employees (provident fund records)
- +13%Revenue CAGR, 3 years
- +9%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Generica India Limited are on its company page.
Detailed financial statements for Generica India
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Generica India
Generica India has 3 listed similar companies in our database, 3 of them funded. They include Entero Healthcare, Keimed and Sandor Medicaids.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| enterohealthcare.com | 2018 | Mumbai, India | $59.67M | 817 | India's leading healthcare products distribution platform | |
| keimed.com | 2000 | Hyderabad, India | $16.62M | 588 | Temperature-sensitive medicines are distributed via cold chain logistics by Keimed. | |
| sandor.co.in | 1995 | Hyderabad, India | $8.98M | 161 | Provider of medical equipment, devices, and drugs distribution services |
Detailed similar companies of Generica India
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Beauty & Personal Care Products
3 companies that operate in the same segment as Generica India (Beauty & Personal Care Products) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Online platform offering a wide range of baby, kids, and maternity products | 2010 | Pune, Maharashtra, India | USD 513.39 M | USD 911.07 M | 3,752 | |
Online brand offering mens grooming products | 2015 | Gurugram, Haryana, India | USD 52.66 M | |||
Retailer of perfumes, cosmetics, skincare, and related gift set items | 2012 | Gurugram, Haryana, India | USD 62.99 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Generica India
Generica India is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
Generica India has 74 employees.
The primary company behind Generica India, Generica India Limited, reported revenue of ₹236 Cr for FY 2025, up 14% year on year.
Generica India Limited operates as a leading healthcare marketing and distribution firm based in Delhi, India. It focuses on partnering with companies like Morepen Laboratories to supply pharmaceutical products across major therapeutic segments. The company emphasizes quality, innovation, and sustainable growth through an extensive distribution network. It serves as national marketing agents for various divisions, handling products from food supplements to sanitizers, and maintains compliance with government norms while prioritizing customer satisfaction and reliable services.
Generica India's top competitors include Entero Healthcare, Keimed and Sandor Medicaids.
Generica India offers Morepen Alpha Products, Morepen Beta Products, Morepen Genesis Products, and DML Lifespring Products.
Generica India operates through Generica India Limited.
The legal entities of Generica India currently have 4 directors, including Amit Mediratta, Hemraj Thakur, Anil Mediratta and others.